Meeting unmet medical needs has its price. Consider the 21st Century Cures legislation. The sweeping Congressional bill, which is designed to jumpstart medical innovation, has a provision that would allow the FDA to grant an extra six months of exclusive marketing rights to a company if an existing drug is approved to treat a rare disease. Jerry Avorn, professor of medicine at Brigham and Women’s Hospital, is quoted.
Electronic devices may be contributing to our sleep-deprived society. Charles Czeisler, Frank Baldino, Jr., Ph.D. Professor of Sleep Medicine at Brigham and Women’s Hospital, is quoted.
State laws have played a big part in boosting the number of hospitals where specialized stroke care is available, a new study shows. Lee Schwamm, professor of neurology at Massachusetts General Hospital, is quoted.
New research suggests that inflated diagnoses by health insurance companies and companies they consult with cost the government billions a year. Timothy Layton, research fellow in health care policy, is a study co-author.
Researchers will begin recruiting cancer survivors who completed treatments at least six months earlier but are still experiencing moderate to severe levels of cancer-related fatigue for an open-label placebo trial. Ted Kaptchuk, professor of medicine at Beth Israel Deaconess Medical Center, is a coleader of the research.
James Hopper, part-time instructor in psychology at Cambridge Health Alliance, authored this article about why people don’t always respond to an attack the way others might expect.
Harold Bursztajn, part-time associate professor of psychiatry at Beth Israel Deaconess Medical Center, fielded questions and comments during a CNN Parents Facebook chat about mental illness and addiction.
